{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:08:50Z","timestamp":1791994130863,"version":"4.4.0"},"reference-count":37,"publisher":"The Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10,1]]},"DOI":"10.1210\/jc.2009-0870","type":"journal-article","created":{"date-parts":[[2009,7,22]],"date-time":"2009-07-22T01:49:44Z","timestamp":1248227384000},"page":"3842-3848","source":"Crossref","is-referenced-by-count":145,"title":["Omega-3 Fatty Acid Supplementation Decreases Liver Fat Content in Polycystic Ovary Syndrome: A Randomized Controlled Trial Employing Proton Magnetic Resonance Spectroscopy"],"prefix":"10.1210","volume":"94","author":[{"given":"Andrea J.","family":"Cussons","sequence":"first","affiliation":[{"name":"University of Western Australia (A.J.C., G.F.W., T.A.M., B.G.A.S.), School of Medicine and Pharmacology, Royal Perth Hospital, Perth 6847, Western Australia"},{"name":"Department of Endocrinology and Diabetes (A.J.C.), Royal Perth Hospital, Perth 6847, Western Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald F.","family":"Watts","sequence":"additional","affiliation":[{"name":"University of Western Australia (A.J.C., G.F.W., T.A.M., B.G.A.S.), School of Medicine and Pharmacology, Royal Perth Hospital, Perth 6847, Western Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor A.","family":"Mori","sequence":"additional","affiliation":[{"name":"University of Western Australia (A.J.C., G.F.W., T.A.M., B.G.A.S.), School of Medicine and Pharmacology, Royal Perth Hospital, Perth 6847, Western Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronwyn G. A.","family":"Stuckey","sequence":"additional","affiliation":[{"name":"University of Western Australia (A.J.C., G.F.W., T.A.M., B.G.A.S.), School of Medicine and Pharmacology, Royal Perth Hospital, Perth 6847, Western Australia"},{"name":"Keogh Institute for Medical Research (B.G.A.S.), Nedlands 6009, Western Australia"},{"name":"Department of Endocrinology and Diabetes (B.G.A.S.), Sir Charles Gairdner Hospital, Nedlands 6009, Western Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041114084947400_R1","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society.","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041114084947400_R2","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome.","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114084947400_R3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.atherosclerosis.2005.10.007","article-title":"Cardiovascular disease in the polycystic ovary syndrome: new insights and perspectives.","volume":"185","author":"Cussons","year":"2006","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t2019041114084947400_R4","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1210\/jc.2005-2774","article-title":"Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome.","volume":"91","author":"Setji","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114084947400_R5","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.fertnstert.2004.08.020","article-title":"Abnormal aminotransferase activity in women with polycystic ovary syndrome.","volume":"83","author":"Schwimmer","year":"2005","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041114084947400_R6","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jhep.2007.04.012","article-title":"Nonalcoholic fatty liver disease in women with polycystic ovary syndrome.","volume":"47","author":"Cerda","year":"2007","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t2019041114084947400_R7","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cgh.2006.10.010","article-title":"Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.","volume":"5","author":"Gambarin-Gelwan","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t2019041114084947400_R8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1440-1746.2008.05740.x","article-title":"An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.","volume":"24","author":"Brzozowska","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t2019041114084947400_R9","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease.","volume":"346","author":"Angulo","year":"2002","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114084947400_R10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1053\/jhep.2002.30692","article-title":"NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome.","volume":"35","author":"Chitturi","year":"2002","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t2019041114084947400_R11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jhep.2008.05.003","article-title":"Liver and heart: a new link?","volume":"49","author":"Bellentani","year":"2008","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t2019041114084947400_R12","doi-asserted-by":"crossref","first-page":"E462","DOI":"10.1152\/ajpendo.00064.2004","article-title":"Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population","volume":"288","author":"Szczepaniak","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114084947400_R13","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/gast.2002.33573","article-title":"Nonalcoholic fatty liver disease.","volume":"122","author":"Clark","year":"2002","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2019041114084947400_R14","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/hep.20251","article-title":"Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss.","volume":"39","author":"Dixon","year":"2004","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t2019041114084947400_R15","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/MOL.0b013e328317cc42","article-title":"The trials and tribulations of the treatment of nonalcoholic fatty-liver disease.","volume":"19","author":"Gan","year":"2008","journal-title":"Curr Opin Lipidol"},{"key":"key\n\t\t\t\t2019041114084947400_R16","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/01.TP.0000150023.86487.44","article-title":"Omega-3 fatty acids improve hepatic steatosis in a murine model: potential implications for the marginal steatotic liver donor.","volume":"79","author":"Alwayn","year":"2005","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t2019041114084947400_R17","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1365-2036.2006.02885.x","article-title":"Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study.","volume":"23","author":"Capanni","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t2019041114084947400_R18","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.dld.2007.10.003","article-title":"Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease.","volume":"40","author":"Spadaro","year":"2008","journal-title":"Dig Liver Dis"},{"key":"key\n\t\t\t\t2019041114084947400_R19","doi-asserted-by":"crossref","first-page":"6395","DOI":"10.3748\/wjg.14.6395","article-title":"Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia.","volume":"14","author":"Zhu","year":"2008","journal-title":"World J Gastroenterol"},{"key":"key\n\t\t\t\t2019041114084947400_R20","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11883-004-0087-5","article-title":"Omega-3 fatty acids and inflammation.","volume":"6","author":"Mori","year":"2004","journal-title":"Curr Atheroscler Rep"},{"key":"key\n\t\t\t\t2019041114084947400_R21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1179\/135100004225005200","article-title":"Effect of fish and fish oil-derived omega-3 fatty acids on lipid oxidation.","volume":"9","author":"Mori","year":"2004","journal-title":"Redox Rep"},{"key":"key\n\t\t\t\t2019041114084947400_R22","first-page":"337","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","author":"Zawadski","year":"1992","journal-title":"In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell;"},{"key":"key\n\t\t\t\t2019041114084947400_R23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041114084947400_R24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"key\n\t\t\t\t2019041114084947400_R25","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2337\/diabetes.49.5.749","article-title":"Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients.","volume":"49","author":"Ryysy","year":"2000","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041114084947400_R26","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t2019041114084947400_R27","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1463-1326.2005.00543.x","article-title":"Measurement of liver fat by magnetic resonance imaging: relationships with body fat distribution, insulin sensitivity and plasma lipids in healthy men.","volume":"8","author":"Chan","year":"2006","journal-title":"Diabetes Obes Metab"},{"key":"key\n\t\t\t\t2019041114084947400_R28","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1053\/j.gastro.2007.11.038","article-title":"Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.","volume":"134","author":"Fabbrini","year":"2008","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2019041114084947400_R29","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.cld.2004.04.005","article-title":"Lipid metabolism in hepatic steatosis","volume":"8","author":"Bradbury","year":"2004","journal-title":"Clin Liver Dis"},{"key":"key\n\t\t\t\t2019041114084947400_R30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.atherosclerosis.2007.11.008","article-title":"Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives.","volume":"197","author":"Harris","year":"2008","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t2019041114084947400_R31","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MOL.0b013e3282ffaf6a","article-title":"N-3 polyunsaturated fatty acid regulation of hepatic gene transcription.","volume":"19","author":"Jump","year":"2008","journal-title":"Curr Opin Lipidol"},{"key":"key\n\t\t\t\t2019041114084947400_R32","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/ajcn\/86.2.324","article-title":"Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men.","volume":"86","author":"Kelley","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"key\n\t\t\t\t2019041114084947400_R33","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.clnu.2008.02.001","article-title":"Omega-3 fatty acid containing diets decrease plasma triglyceride concentrations in mice by reducing endogenous triglyceride synthesis and enhancing the blood clearance of triglyceride-rich particles.","volume":"27","author":"Qi","year":"2008","journal-title":"Clin Nutr"},{"key":"key\n\t\t\t\t2019041114084947400_R34","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1440-1746.2007.05157.x","article-title":"Activation of peroxisome proliferator-activated receptor \u03b1 by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.","volume":"23","author":"Larter","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t2019041114084947400_R35","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1440-1681.2006.04451.x","article-title":"Omega-3 fatty acids and hypertension in humans.","volume":"33","author":"Mori","year":"2006","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"key\n\t\t\t\t2019041114084947400_R36","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00125-008-1135-4","article-title":"Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?","volume":"51","author":"Targher","year":"2008","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041114084947400_R37","article-title":"Dissociation of endothelial function and arterial stiffness in non-obese women with PCOS","author":"Cussons","year":"28 2009","journal-title":"Clin Endocrinol"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/94\/10\/3842\/9058910\/jcem3842.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T21:48:10Z","timestamp":1590011290000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/94\/10\/3842\/2596989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,1]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2009-0870","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,1]]}}}